Skip to main content
. 2015 Nov 6;10(11):e0141660. doi: 10.1371/journal.pone.0141660

Fig 3. Cost-effectiveness plane for DCV/ASV versus PR: The cost-effectiveness plane represents the base case scenario assuming a DCV/ASV total treatment price of US$ 38,710.

Fig 3